Secondary Metabolites from the Coral-Derived Fungus Aspergillus austwickii SCSIO41227 with Pancreatic Lipase and Neuraminidase Inhibitory Activities

Mar Drugs. 2023 Oct 29;21(11):567. doi: 10.3390/md21110567.

Abstract

The coral-derived fungus Aspergillus austwickii SCSIO41227 from Beibu Gulf yielded four previously uncharacterized compounds, namely asperpentenones B-E (1-4), along with twelve known compounds (5-16). Their structures were elucidated using HRESIMS and NMR (1H and 13C NMR, HSQC, HMBC), among which the stereo-structure of compounds 1-3 was determined by calculated ECD. Furthermore, compounds 1-16 were evaluated in terms of their enzyme (acetylcholinesterase (AChE), pancreatic lipase (PL), and neuraminidase (NA)) inhibitory activities. These bioassay results revealed that compounds 2 and 14 exerted noticeable NA inhibitory effects, with IC50 values of 31.28 and 73.64 μM, respectively. In addition, compound 3 exhibited a weak inhibitory effect against PL. Furthermore, these compounds showed the potential of inhibiting enzymes in silico docking analysis to demonstrate the interactions between compounds and proteins.

Keywords: Aspergillus austwickii SCSIO41227; molecular docking; neuraminidase; pancreatic lipase; secondary metabolites.

MeSH terms

  • Acetylcholinesterase / metabolism
  • Animals
  • Anthozoa* / metabolism
  • Aspergillus / chemistry
  • Lipase / metabolism
  • Molecular Structure
  • Neuraminidase*

Substances

  • Neuraminidase
  • Lipase
  • Acetylcholinesterase

Supplementary concepts

  • Aspergillus austwickii